The MicroMed DeBakey VAD - Part I: The Pump and the Blood Flow

Evgenij V. Potapov; Andreas Koster; Matthias Loebe; Ewald Hennig; Thomas Fischer; Ralf Sodian; Roland Hetzer

The MicroMed DeBakey VAD - Part I: The Pump and the Blood Flow

Evgenij V. Potapov, Andreas Koster, Matthias Loebe, Ewald Hennig, Thomas Fischer, Ralf Sodian, Roland Hetzer

Academic Institute

Research output: Contribution to journal › Review article

18 Scopus citations

Abstract

The results obtained in over 100 patients implanted with the MicroMed DeBakey VAD in several centers in Europe and USA (September 2001, M. Loebe, personal communication) demonstrate that the effectiveness of the MicroMed DeBakey VAD is comparable to that of the pulsatile devices and that it also shows some superior properties. Recently, other axial pumps-the Jarvic 2000 (72) and HeartMate II (73)-have come into clinical use. Because the patients show good tolerance of the nonpulsatile blood flow in the early postoperative period, and pulsatility increased with recovery of the left ventricle because of unloading, we believe that the axial pumps will gain wide acceptance and provide a new option in the treatment of heart failure.

Original language	English (US)
Pages (from-to)	274-283
Number of pages	10
Journal	Journal of Extra-Corporeal Technology
Volume	35
Issue number	4
State	Published - Dec 1 2003

ASJC Scopus subject areas

Medicine (miscellaneous)
Health Professions (miscellaneous)
Cardiology and Cardiovascular Medicine

Access to Document

Fingerprint Dive into the research topics of 'The MicroMed DeBakey VAD - Part I: The Pump and the Blood Flow'. Together they form a unique fingerprint.

Cite this

@article{83735daa97ec4aaeb32ccffba733c2a8,

title = "The MicroMed DeBakey VAD - Part I: The Pump and the Blood Flow",

abstract = "The results obtained in over 100 patients implanted with the MicroMed DeBakey VAD in several centers in Europe and USA (September 2001, M. Loebe, personal communication) demonstrate that the effectiveness of the MicroMed DeBakey VAD is comparable to that of the pulsatile devices and that it also shows some superior properties. Recently, other axial pumps-the Jarvic 2000 (72) and HeartMate II (73)-have come into clinical use. Because the patients show good tolerance of the nonpulsatile blood flow in the early postoperative period, and pulsatility increased with recovery of the left ventricle because of unloading, we believe that the axial pumps will gain wide acceptance and provide a new option in the treatment of heart failure.",

author = "Potapov, {Evgenij V.} and Andreas Koster and Matthias Loebe and Ewald Hennig and Thomas Fischer and Ralf Sodian and Roland Hetzer",

year = "2003",

month = dec,

day = "1",

language = "English (US)",

volume = "35",

pages = "274--283",

journal = "Journal of Extra-Corporeal Technology",

issn = "0022-1058",

publisher = "American Society of Extra-Corporeal Technology",

number = "4",

}

TY - JOUR

T1 - The MicroMed DeBakey VAD - Part I

T2 - The Pump and the Blood Flow

AU - Potapov, Evgenij V.

AU - Koster, Andreas

AU - Loebe, Matthias

AU - Hennig, Ewald

AU - Fischer, Thomas

AU - Sodian, Ralf

AU - Hetzer, Roland

PY - 2003/12/1

Y1 - 2003/12/1

N2 - The results obtained in over 100 patients implanted with the MicroMed DeBakey VAD in several centers in Europe and USA (September 2001, M. Loebe, personal communication) demonstrate that the effectiveness of the MicroMed DeBakey VAD is comparable to that of the pulsatile devices and that it also shows some superior properties. Recently, other axial pumps-the Jarvic 2000 (72) and HeartMate II (73)-have come into clinical use. Because the patients show good tolerance of the nonpulsatile blood flow in the early postoperative period, and pulsatility increased with recovery of the left ventricle because of unloading, we believe that the axial pumps will gain wide acceptance and provide a new option in the treatment of heart failure.

AB - The results obtained in over 100 patients implanted with the MicroMed DeBakey VAD in several centers in Europe and USA (September 2001, M. Loebe, personal communication) demonstrate that the effectiveness of the MicroMed DeBakey VAD is comparable to that of the pulsatile devices and that it also shows some superior properties. Recently, other axial pumps-the Jarvic 2000 (72) and HeartMate II (73)-have come into clinical use. Because the patients show good tolerance of the nonpulsatile blood flow in the early postoperative period, and pulsatility increased with recovery of the left ventricle because of unloading, we believe that the axial pumps will gain wide acceptance and provide a new option in the treatment of heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0942287177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942287177&partnerID=8YFLogxK

M3 - Review article

C2 - 14979416

AN - SCOPUS:0942287177

VL - 35

SP - 274

EP - 283

JO - Journal of Extra-Corporeal Technology

JF - Journal of Extra-Corporeal Technology

SN - 0022-1058

IS - 4

ER -